Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
H5N1 Bird Flu Outbreaks: Effect on Vaccines
H5N1 outbreaks in the US have mobilised pandemic preparedness mechanisms with stockpiling of avian flu vaccines.
Drug Discovery & Development
Chronic cardiotoxicity study on H9C2 cells using HESI stem cell working group reference compounds
Biomarkers & Precision Medicine
ScaiPod: The most comprehensive single-cell omics dataset in immuno-oncology
Drug Discovery & Development
ScaiVision AI platform: project workflow to facilitate drug development
Immuno-Oncology
Finding New Immunotherapy Targets for Solid Brain Tumour CAR Ts with RNAseq in Cancer-Specific Exons
The project has found over 150 target candidates for solid brain tumour therapies.
"World's First" IND Approval for Epstein-Barr mRNA Cancer Vaccine
Epstein-Barr virus has been highly linked to over ten forms of cancer. This wide range of malignant implications means an expanded variety of target indications for the vaccine.